Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TURQUOISE-CPB: AbbVie 3D/2D Regimen in HCV with Decompensated Cirrhosis
NCT02219477Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ombitasvir + paritaprevir + ritonavir, dasabuvir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Nov 2014; status: completed.
02
Drugs
ombitasvir + paritaprevir + ritonavirdasabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02219477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219477.